← Browse by Condition
Medical Condition
obesity overweight
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 3, EARLY_Phase 1, Phase 2
NCT07448090
Recruiting
Real-World Registry Study of Integrated Traditional Chinese and Western Medicine for Obesity
Enrollment
10,000 pts
Location
China
Sponsor
Hubei Hospital of Traditional ...
NCT07227051
Recruiting
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health ...
NCT07279194 Phase 3
Recruiting
Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes
Enrollment
825 pts
Location
China
Sponsor
Hangzhou Zhongmei Huadong Phar...
NCT07300332
Recruiting
Exercise Training and Vitamin D Metabolism
Enrollment
30 pts
Location
Greece
Sponsor
University of Thessaly
NCT07261475 EARLY_Phase 1
Recruiting
Crocus Sativus Tepals Water Extract in Obesity and Prediabetes
Enrollment
20 pts
Location
Slovenia
Sponsor
University of Primorska
NCT07229027
Recruiting
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
Enrollment
500 pts
Location
United Kingdom
Sponsor
Medialis Ltd.
NCT07262762
Recruiting
Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
Enrollment
175 pts
Location
Iran
Sponsor
Cinnagen
NCT07141342
Recruiting
Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Participate in a Weight Loss Program, Half Will Receive Bed Scales, and Participants Who Receive the Bed Scales Are Expected to Have Increased Weight Loss.
Enrollment
92 pts
Location
United States
Sponsor
Jonathan Pearlman
NCT07364175
Recruiting
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults
Enrollment
60 pts
Location
United Kingdom
Sponsor
Cambridge University Hospitals...
NCT07336797 Phase 2
Recruiting
Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Enrollment
66 pts
Location
Egypt
Sponsor
Abdelrahman Mahmoud